Talk:Streptococcus agalactiae: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Deena Berkowitz
No edit summary
imported>Deena Berkowitz
No edit summary
Line 23: Line 23:
==Cell structure and metabolism==
==Cell structure and metabolism==
S. agalactiae are facultative anerobes that are both B-hemoltyic and non hemolytic<ref name=txtbk /> (hemolysis is the breakdown of red blood cells before the natural course of the red blood cell’s life). <ref>Medline Plus. 20 April 2002 http://www.nlm.nih.gov/medlineplus/ency/article/002372.htm/ref>
S. agalactiae are facultative anerobes that are both B-hemoltyic and non hemolytic<ref name=txtbk /> (hemolysis is the breakdown of red blood cells before the natural course of the red blood cell’s life). <ref>Medline Plus. 20 April 2002 http://www.nlm.nih.gov/medlineplus/ency/article/002372.htm/ref>
Different strains of streptococcus agalactiae have been identified by serologic markers that have classified different groups based on the prescence of either a B antigen or group specific cell wall polysaccharide antigen, a type-specific capsular polysaccharides or the presence of the surface (C) protein. The type-specific capsular polysaccharides have been lableled Ia, Ia/c, Ib/c, II, IIc, III, IV, V, VI, VII, VIII and are used as epidemiologic markers. <ref name=txtbk />  
Different strains of streptococcus agalactiae have been identified by serologic markers that have classified different groups based on the prescence of either a B antigen or group specific cell wall polysaccharide antigen, a type-specific capsular polysaccharides or the presence of the surface (C) protein. The type-specific capsular polysaccharides have been lableled Ia, Ia/c, Ib/c, II, IIc, III, IV, V, VI, VII, VIII and are used as epidemiologic markers. <ref name=txtbk />  



Revision as of 23:04, 22 April 2009

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
To learn how to update the categories for this article, see here. To update categories, edit the metadata template.
 Definition Beta-hemolytic Gram-positive streptococcus, which is a major cause of bacterial septicemia of the newborn, which can lead to death or long-term sequelae, and neonatal meningitis. [d] [e]
Checklist and Archives
 Workgroup categories Biology and Health Sciences [Editors asked to check categories]
 Subgroup category:  Microbiology
 Talk Archive none  English language variant British English
All unapproved Citizendium articles may contain errors of fact, bias, grammar etc. A version of an article is unapproved unless it is marked as citable with a dedicated green template at the top of the page, as in this version of the 'Biology' article. Citable articles are intended to be of reasonably high quality. The participants in the Citizendium project make no representations about the reliability of Citizendium articles or, generally, their suitability for any purpose.

Attention niels epting.png
Attention niels epting.png
This article is currently being developed as part of an Eduzendium student project in the framework of a course entitled Microbiology 201 at Queens College, CUNY. The course homepage can be found at CZ:Biol 201: General Microbiology.
For the course duration, the article is closed to outside editing. Of course you can always leave comments on the discussion page. The anticipated date of course completion is May 21, 2009. One month after that date at the latest, this notice shall be removed.
Besides, many other Citizendium articles welcome your collaboration!


Streptococcus Agalactiae
Scientific classification
Binomial name
Streptococcus Agalactiae

Description and significance

Streptococcus Agalactiae, also known as Group B streptococci are gram positive cocci that range from 0.6 to 1.2 um. These cocci arrange themselves in chains, forming shorter chains in clinical specimens and longer chains in a culture specimen. They are distinguished from other streptococci by the presence of the group B antigen.[1]

S. agalactiae colonizes in a woman’s vaginal and gastrointestinal tracts in a commensal relationship that is present in 25-40% of healthy women. When the organism is introduced to a weakened or susceptible host (including individuals with compromised immunity and newborns), S. Agalactiae causes bacterial sepsis, pneumonia and meningitis in newborns and can also cause postpartum infection, neonatal sepsis and other infections in infected hosts. [2] [3]

Cell structure and metabolism

S. agalactiae are facultative anerobes that are both B-hemoltyic and non hemolytic[1] (hemolysis is the breakdown of red blood cells before the natural course of the red blood cell’s life). <ref>Medline Plus. 20 April 2002 http://www.nlm.nih.gov/medlineplus/ency/article/002372.htm/ref> Different strains of streptococcus agalactiae have been identified by serologic markers that have classified different groups based on the prescence of either a B antigen or group specific cell wall polysaccharide antigen, a type-specific capsular polysaccharides or the presence of the surface (C) protein. The type-specific capsular polysaccharides have been lableled Ia, Ia/c, Ib/c, II, IIc, III, IV, V, VI, VII, VIII and are used as epidemiologic markers. [1]

The cell structure of S. agalactiae helps to contribute to the organism’s virulence in several different ways. S. agalactiae contains a thick peptidoglycan cell wall layer which prevents dessication and allows for the organism to live on dry surfaces. The capsular polysaccharides Ia, III and V further contribute to the organism’s virulence by preventing the immune response of complement mediated phagocytosis. In addition, the organism’s virulence is heightened by the presence of hydrolytic enzymes that aide in the spread of bacteria and allow for host tissue destruction. [1]



Genome structure

Ecology

Pathology

Application to Biotechnology

Current Research

References

  1. 1.0 1.1 1.2 1.3 R. Murray, S. Rosenthal and A. Pfaller. “Streptococcus.” Medical Microbiology, Fifth Edition, Chapter 23, p. 247-250, (2005)Elsevier Mosby
  2. Tettelin, Herve et. Al. “Complete genome sequence and comparitive genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.” PNAS. September 2002. Vol. 99, no. 19, 12391-12396.
  3. Woods, Christian J. “Streptococcus Group B Infections.” Emedicine http://emedicine.medscape.com/article/229091-overview